Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis
H MotieGhader, E Safavi, A Rezapour, FF Amoodizaj… - Scientific reports, 2021 - nature.com
Severe acute respiratory syndrome (SARS) is a highly contagious viral respiratory illness.
This illness is spurred on by a coronavirus known as SARS-associated coronavirus (SARS …
This illness is spurred on by a coronavirus known as SARS-associated coronavirus (SARS …
Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis
M Adhami, B Sadeghi, A Rezapour, AA Haghdoost… - BMC …, 2021 - Springer
Background The coronavirus disease-19 (COVID-19) emerged in Wuhan, China and rapidly
spread worldwide. Researchers are trying to find a way to treat this disease as soon as …
spread worldwide. Researchers are trying to find a way to treat this disease as soon as …
[HTML][HTML] Network bioinformatics analysis provides insight into drug repurposing for COVID-19
X Li, J Yu, Z Zhang, J Ren, AE Peluffo, W Zhang… - Medicine in Drug …, 2021 - Elsevier
The COVID-19 disease caused by the SARS-CoV-2 virus is a health crisis worldwide. While
developing novel drugs and vaccines is long, repurposing existing drugs against COVID-19 …
developing novel drugs and vaccines is long, repurposing existing drugs against COVID-19 …
Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing
The ongoing COVID-19 pandemic caused by the coronavirus, SARS-CoV-2, has already
caused in excess of 1.25 million deaths worldwide, and the number is increasing …
caused in excess of 1.25 million deaths worldwide, and the number is increasing …
Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach
T Loganathan, S Ramachandran, P Shankaran… - PeerJ, 2020 - peerj.com
Background Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has been declared a pandemic by the World Health …
syndrome coronavirus 2 (SARS-CoV-2) has been declared a pandemic by the World Health …
A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection
SZ Mousavi, M Rahmanian, A Sami - Infection, Genetics and Evolution, 2020 - Elsevier
Aims The recent outbreak of COVID-19 has become a global health concern. There are
currently no effective treatment strategies and vaccines for the treatment or prevention of this …
currently no effective treatment strategies and vaccines for the treatment or prevention of this …
DTSEA: a network-based drug target set enrichment analysis method for drug repurposing against COVID-19
Y Su, J Wu, X Li, J Li, X Zhao, B Pan, J Huang… - Computers in Biology …, 2023 - Elsevier
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic is still wreaking havoc
worldwide. Therefore, the urgent need for efficient treatments pushes researchers and …
worldwide. Therefore, the urgent need for efficient treatments pushes researchers and …
In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential …
A Lopez-Cortes, P Guevara-Ramirez… - Frontiers in …, 2021 - frontiersin.org
Background: There is pressing urgency to identify therapeutic targets and drugs that allow
treating COVID-19 patients effectively. Methods: We performed in silico analyses of immune …
treating COVID-19 patients effectively. Methods: We performed in silico analyses of immune …
[HTML][HTML] In silico drug repurposing to combat COVID-19 based on pharmacogenomics of patient transcriptomic data
S Das, K Camphausen, U Shankavaram - Research square, 2020 - ncbi.nlm.nih.gov
The ongoing global pandemic of coronavirus disease 2019 (COVID-19) continues to affect a
growing number of populations in different parts of the world. In the current situation, drug …
growing number of populations in different parts of the world. In the current situation, drug …
Drug repurposing for COVID-19 treatment by integrating network pharmacology and transcriptomics
Since coronavirus disease 2019 (COVID-19) is a serious new worldwide public health crisis
with significant morbidity and mortality, effective therapeutic treatments are urgently needed …
with significant morbidity and mortality, effective therapeutic treatments are urgently needed …
相关搜索
- sars cov drug repurposing
- sars cov integrative analysis
- transcriptome analysis drug repurposing
- interaction network candidate drugs
- coronavirus disease candidate drugs
- coronavirus disease interaction network
- mers cov transcriptome analysis
- sars cov connectivity map
- sars cov transcriptomic profiling
- sars cov transcriptome analysis
- mers cov drug repurposing